Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 218

Similar articles for PubMed (Select 16040288)

1.

Low blast count myeloid disorders with Auer rods: a clinicopathologic analysis of 9 cases.

Willis MS, McKenna RW, Peterson LC, Coad JE, Kroft SH.

Am J Clin Pathol. 2005 Aug;124(2):191-8.

2.

The prognostic significance of auer rods in myelodysplasia.

Seymour JF, Estey EH.

Br J Haematol. 1993 Sep;85(1):67-76.

PMID:
8251411
3.

Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals.

Strupp C, Gattermann N, Giagounidis A, Aul C, Hildebrandt B, Haas R, Germing U.

Leuk Res. 2003 May;27(5):397-404.

PMID:
12620291
4.

Proposals for the classification of the myelodysplastic syndromes.

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C.

Br J Haematol. 1982 Jun;51(2):189-99.

PMID:
6952920
5.

Auer rods in mature granulocytes: a unique morphologic feature of acute myelogenous leukemia with maturation.

Stass SA, Lanham GR, Butler D, Williams DL, Peiper SC, Kalwinsky DK, Dahl GV.

Am J Clin Pathol. 1984 May;81(5):662-5.

PMID:
6586071
6.
7.

[Incidence and prognostic significance of Auer rods in children with acute myeloid leukemia in the studies AML-BFM-78 and -83].

Vormoor J, Ritter J, Creutzig U, Schellong G.

Klin Padiatr. 1989 Jul-Aug;201(4):227-32. German.

PMID:
2674529
8.

Trisomy 14 in myelodysplastic syndromes: report of two cases and review of the literature.

Vasef MA, Murata-Collins JL, Alsabeh R, Medeiros LJ.

Arch Pathol Lab Med. 1998 Jan;122(1):77-83. Review.

PMID:
9448022
9.

Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry.

van de Loosdrecht AA, Westers TM, Westra AH, Dräger AM, van der Velden VH, Ossenkoppele GJ.

Blood. 2008 Feb 1;111(3):1067-77. Epub 2007 Oct 30.

10.

Prognostic significance of Auer rods in childhood acute myelogenous leukemia: results of the studies AML-BFM-78 and -83.

Ritter J, Vormoor J, Creutzig U, Schellong G.

Med Pediatr Oncol. 1989;17(3):202-9.

PMID:
2546027
11.

Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome.

Ogata K, Nakamura K, Yokose N, Tamura H, Tachibana M, Taniguchi O, Iwakiri R, Hayashi T, Sakamaki H, Murai Y, Tohyama K, Tomoyasu S, Nonaka Y, Mori M, Dan K, Yoshida Y.

Blood. 2002 Dec 1;100(12):3887-96. Epub 2002 Jul 18.

13.

Trisomy 21 as the sole acquired karyotypic abnormality in acute myeloid leukemia and myelodysplastic syndrome.

Wan TS, Au WY, Chan JC, Chan LC, Ma SK.

Leuk Res. 1999 Nov;23(11):1079-83.

PMID:
10576514
14.
15.

Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.

Jiang Y, Dunbar A, Gondek LP, Mohan S, Rataul M, O'Keefe C, Sekeres M, Saunthararajah Y, Maciejewski JP.

Blood. 2009 Feb 5;113(6):1315-25. doi: 10.1182/blood-2008-06-163246. Epub 2008 Oct 2.

16.

[Myelodysplastic syndromes: preleukemic syndromes].

Tassin F, Hermanne JP, Schaaf-Lafontaine N, Herens C, Thiry A, Paulus JM, Boniver J, Fillet G.

Rev Med Liege. 1998 Jun;53(6):357-62. Review. French.

PMID:
9713217
17.
18.
19.

Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia.

Kussick SJ, Fromm JR, Rossini A, Li Y, Chang A, Norwood TH, Wood BL.

Am J Clin Pathol. 2005 Aug;124(2):170-81.

20.

Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals.

Germing U, Strupp C, Kuendgen A, Aivado M, Giagounidis A, Hildebrandt B, Aul C, Haas R, Gattermann N.

Br J Haematol. 2006 Jan;132(2):162-7. Erratum in: Br J Haematol. 2006 Jul;134(2):247.

PMID:
16398650
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk